The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 2,403,484 | 67,400 | SH | SOLE | 67,400 | 0 | 0 | |||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 2,858,640 | 166,200 | SH | SOLE | 166,200 | 0 | 0 | |||
| CURIS INC | COM NEW | 231269200 | 4,980,000 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | |||
| INVIVYD INC | COM | 00534A102 | 9,710,663 | 9,248,250 | SH | SOLE | 9,248,250 | 0 | 0 | |||
| NEXIMMUNE INC | COM | 65344D109 | 37,604 | 133,442 | SH | SOLE | 133,442 | 0 | 0 | |||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 3,095,172 | 1,910,600 | SH | SOLE | 1,910,600 | 0 | 0 | |||
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 12,525,651 | 630,380 | SH | SOLE | 630,380 | 0 | 0 | |||
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 2,000,900 | 363,800 | SH | SOLE | 363,800 | 0 | 0 | |||
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 5,183,694 | 197,700 | SH | SOLE | 197,700 | 0 | 0 | |||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 3,680,000 | 346,190 | SH | SOLE | 197,700 | 0 | 0 | |||
| TG THERAPEUTICS INC | COM | 88322Q108 | 3,539,700 | 142,500 | SH | SOLE | 142,500 | 0 | 0 | |||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 25,662,000 | 7,050,000 | SH | SOLE | 7,050,000 | 0 | 0 | |||